IL6 and cancer: Finally, approaching the tumor microenvironment, such as interrupting the immune cells and cytokines (e.g. IL-6, IL-8) as well as the immune checkpoints (PD1/PDL1) may provide additional new tools for immunological killing of cancer stem cells [40, 41, 42]